This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Imperial Innovations Limited. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Napoli, IT (2015)
- Naples, IT (2016)
Company Filing History:
Years Active: 2015-2016
Title: Simona Maria Monti: Innovator in Cancer Treatment
Introduction
Simona Maria Monti is a distinguished inventor based in Naples, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer and inflammatory diseases. With a total of 2 patents, her work is recognized for its innovative approach to targeting specific agents in medical applications.
Latest Patents
Monti's latest patents focus on Gadd45beta targeting agents. These patents include compounds based around tetrapeptide, tripeptide, and dipeptide moieties, along with corresponding peptoid moieties. The related methods and pharmaceutical compositions are designed for use in the treatment of cancer, inflammatory diseases, and other disorders. This innovative work showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Simona Maria Monti is associated with Imperial Innovations Limited, where she continues to push the boundaries of pharmaceutical research. Her career is marked by a dedication to developing effective treatments that address critical health issues. Monti's expertise and innovative spirit have positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include Guido Franzoso and Albert Andrzej Jaxa-Chamiec. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
Simona Maria Monti's work exemplifies the impact of innovation in the medical field. Her patents and collaborations reflect a commitment to improving health outcomes through targeted therapies. Monti's contributions are paving the way for future advancements in cancer treatment and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile